Production of biologically active human interleukin-10 by Bifidobacterium bifidum BGN4
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2859
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Production of biologically active human interleukin-10 by Bifidobacterium bifidum BGN4 ; volume:20 ; number:1 ; day:19 ; month:1 ; year:2021 ; pages:1-14 ; date:12.2021
Microbial cell factories ; 20, Heft 1 (19.1.2021), 1-14, 12.2021
- Urheber
-
Hong, Nayoun
Ku, Seockmo
Yuk, Kyungjin
Johnston, Tony V.
Ji, Geun Eog
Park, Myeong Soo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12934-020-01505-y
- URN
-
urn:nbn:de:101:1-2021031020203906379388
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hong, Nayoun
- Ku, Seockmo
- Yuk, Kyungjin
- Johnston, Tony V.
- Ji, Geun Eog
- Park, Myeong Soo
- SpringerLink (Online service)
Ähnliche Objekte (12)
A designer hyper interleukin 11 (H11) is a biologically active cytokine
Biologically active ether lipids
Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1β
Can erythrocytes release biologically active NO?
Biologically active secondary metabolites from Actinomycetes
On Biologically Active Substances in Our Crops
Biologically Active Substances from the Genus Artemisia
Synthesis and immobilisation of biologically active substances
Periplasmic Delivery of Biologically Active Human Interleukin-10 in Escherichia coli via a Sec-Dependent Signal Peptide
Production of biologically active recombinant buffalo leukemia inhibitory factor (BuLIF) in Escherichia Coli
Erbliche Stoffwechselkrankheiten : = Genetic Defects of biologically active proteins
Syntheses and characterization of biologically active gold nanoparticles
A designer hyper interleukin 11 (H11) is a biologically active cytokine
Biologically active ether lipids
Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1β
Can erythrocytes release biologically active NO?
Biologically active secondary metabolites from Actinomycetes
On Biologically Active Substances in Our Crops
Biologically Active Substances from the Genus Artemisia
Synthesis and immobilisation of biologically active substances
Periplasmic Delivery of Biologically Active Human Interleukin-10 in Escherichia coli via a Sec-Dependent Signal Peptide
Production of biologically active recombinant buffalo leukemia inhibitory factor (BuLIF) in Escherichia Coli
Erbliche Stoffwechselkrankheiten : = Genetic Defects of biologically active proteins
Syntheses and characterization of biologically active gold nanoparticles
A designer hyper interleukin 11 (H11) is a biologically active cytokine
Biologically active ether lipids
Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1β
Can erythrocytes release biologically active NO?
Biologically active secondary metabolites from Actinomycetes
On Biologically Active Substances in Our Crops
Biologically Active Substances from the Genus Artemisia
Synthesis and immobilisation of biologically active substances
Periplasmic Delivery of Biologically Active Human Interleukin-10 in Escherichia coli via a Sec-Dependent Signal Peptide
Production of biologically active recombinant buffalo leukemia inhibitory factor (BuLIF) in Escherichia Coli
Erbliche Stoffwechselkrankheiten : = Genetic Defects of biologically active proteins